Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative TPF in Molecularly Selected Oral Cavity Cancer
NCT01914900Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jun 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, cisplatin, fluorouracil in oral cavity squamous cell carcinoma (OCSCC), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Started Jun 2012; status: completed.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
oral cavity squamous cell carcinoma (OCSCC)
Beyond the preview
Go deeper on NCT01914900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01914900.